VBP1 promotes tumor proliferation as a part of the hypoxia-related signature in esophageal squamous cell carcinoma

Huikai Miao,Wuyou Gao,Leqi Zhong,Hongmu Li,Dongni Chen,Chunmei Xu,Zhesheng Wen,Youfang Chen

DOI: https://doi.org/10.1007/s13577-024-01068-9

2024-05-08

Human Cell

Abstract:Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor in East Asia. Hypoxia, a hallmark of solid tumors, significantly alters redox homeostasis inside tumor microenvironment. This alteration drives tumor proliferation, invasion, and metastasis, leading to poor prognostic outcomes. However, the role of hypoxia-related genes in ESCC remains poorly understood. We employed RNA sequencing to identify differentially expressed genes in ESCC. Clinical data, transcriptome profiles, and a hypoxia-related gene set were extracted from open-source databases. A prognostic model was constructed using least absolute shrinkage and selection operator (LASSO) regression, which was then validated through Cox regression analysis. Within this prognostic model, we pinpointed and investigated a key hypoxia-related gene affecting prognosis. The gene's expression was validated using real-time PCR and immunohistochemistry in both esophageal carcinoma and normal tissues. Tumor proliferation was examined through in vitro and in vivo assays, including the Cell Counting Kit-8, EdU, colony formation, and subcutaneous tumor models. A robust four-gene prognostic model (VBP1, BGN, CDKN1A, and PPFIA1) was successfully constructed and validated. Among these, VBP1 emerged as a key gene, exhibiting high expression levels that correlated with poor prognosis in ESCC. Functional experiments confirmed that VBP1 significantly accelerated tumor proliferation both in vitro and in vivo. VBP1 is identified as a pivotal gene within the hypoxia-related prognostic signature, and it significantly promotes tumor proliferation in ESCC.

cell biology

What problem does this paper attempt to address?

This paper mainly discusses how low oxygen environment-related genes affect tumor proliferation in esophageal squamous cell carcinoma (ESCC). The researchers identified differentially expressed genes between ESCC and normal tissues through RNA sequencing, and extracted clinical data, transcriptome profiles, and hypoxia-related gene sets from open-source databases. They constructed a prediction model based on Least Absolute Shrinkage and Selection Operator (LASSO) regression, and validated it using Cox regression analysis.

In this prediction model, the researchers found a key hypoxia-related gene called VBP1 (VHL-binding protein 1), which was associated with poor prognosis in ESCC patients when highly expressed. The expression difference of VBP1 between esophageal cancer and normal tissues was validated through real-time PCR and immunohistochemistry, and its significant promoting effect on tumor proliferation was demonstrated through in vitro and in vivo experiments including Cell Counting Kit-8, EdU, colony formation, and subcutaneous tumor models.

Furthermore, the study also showed that VBP1, as a hypoxia-related gene, is involved in pathways such as DNA replication and homologous recombination, which may accelerate tumor growth. In experiments simulating low oxygen environments, the protein level of VBP1 increased with the concentration of cobalt chloride (CoCl2), suggesting its association with hypoxia.

In conclusion, this paper reveals the crucial role of VBP1 as a hypoxia-related marker in ESCC, where its upregulation promotes tumor proliferation. The paper also proposes a prognostic model consisting of four genes, which can contribute to the improvement of clinical prediction for ESCC.